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ABSTRACT
Controversy regarding the role of SIRT1 in pathology of cancers exists and is still under debate.
SIRT1 could act as either a tumor supressor or tumor promotor. This study was conducted to
evaluate the relationship between SIRT1 expression and tumor size, Proliferating Cell Nuclear
Antigen (PCNA) expression and histological grading in rat breast carcinoma induced by
dimethylbenz(á)anthracene (DMBA). Thirty female Sprague Dawley rats were randomly allocated
into three groups with 10 rats in each group. Group 1 as negative control was just fed the
standard food. Group 2 as vehicle control was fed the standard food and corn oil. Group 3 as
induction group was fed the standard food and induced with DMBA at dose of 20 mg/kg body
weight (BW) in corn oil twice a week for five weeks. All rats were palpated weekly to determine
the appearance, size and location of tumors. Sixteen weeks after DMBA induction rats were
sacrified and histological preparations of the breast carcinoma tissue were then processed for
SIRT1 and PCNA expression examination as well as histological grading. The result showed that
SIRT1 expression was significantly higher in breast carcinoma tissue compared to normal gland
(26.12 vs 0.05; p = 0.004). SIRT1-positive was observed mostly in poor histological grade
carcinomas (56.2%), and it was not observed in good histological grade carcinomas. However,
there was no significantly difference between SIRT1 and histological grading (p = 0.097; r =
0.285). A significant correlation between SIRT1 expression and the tumor size (p =0.009; r
=0.877), as well as PCNA expression (p =0.000; r =0.790) was observed. In conclusion, there
is relationship between SIRT1 expression and tumor size as well as PCNA expression in rat breast
carcinoma induced by DMBA.
ABSTRAK
Kontrovesi mengenai peran SIRT1 dalam patologi kanker muncul dan masih diperdebatkan. SIRT1
dapat berperan sebagai penekan atau pemacu pertumbuhan tumor. Penelitian ini dilakukan untuk
mengkaji hubungan antara SIRT1 dengan ukuran tumor, ekspresi Proliferating Cell Nuclear Antigen
(PCNA) dan derajat histologi pada kanker payudara tikus yang diinduksi oleh dimetilbenz()antrasen
(DMBA). Tiga puluh tikus Sprague Dawley betina dibagi secara acak menjadi tiga kelompok
dengan masing-masing kelompok 10 ekor. Kelompok 1 sebagai kontrol negatif hanya diberi
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pakan standar. Kelompok 2 sebagai kontrol pembawa diberi pakan standar dan pembawa.
Kelompok 3 sebagai kelompok induksi diberi pakan standar dan diinduksi dengan DMBA dosis
20 mg/kg berat badan (BB) dalam minyak jagung dua kali seminggu selama lima minggu. Semua
tikus dipalpitasi setiap minggu untuk terjadinya tumor, ukuran dan lokasinya. Enam belas minggu
setelah induksi DMBA, tikus dikorbankan dan dibuta preparat histologi jaringan kanker payudaranya
untuk pemeriksaan ekspresi SIRT1 dan PCNA maupun derajad histologinya. Hasil penelitian
menunjukkan ekspresi SIRT1 lebih tinggi secara nyata pada jaringan kanker dibandingkan jaringan
normal (26,12 vs 0,05; p = 0.004). SIRT 1 positif dijumpai di hampir semua jaringan histologi
derajad buruk (56,2%) and tidak dijumpai di jaringan histologi derajad baik. Namun demikian
tidak terdapat hubungan bermakan antara ekspresi SIRT1 dengan dejarad histologi (p = 0,097; r
= 0,285). Hubungan bermakna dijumpai antara ekspresi SIRT1 dengan ukuran tumor (p =
0,009; r = 0,877) demikian juga dengan ekspresi PCNA (p = 0,000; r = 0,790). Dapat disimpulkan,
ada hubungan antara ekspresi SIRT1 dengan ukuran tumor dan ekspresi PCNA pada kanker
payudara tikus yang diinduksi dengan DMBA.
Keywords: SIRT1 expression - DMBA induced rat breast cancer - histological grading - tumor
size - PCNA expression
INTRODUCTION
The silent information regulator (SIR) genes
(sirtuin) are a class of proteins that possess
either mono-ADP-ribosyltransferase, or
deacylase activity. Sirtuin present from bacteria
to mamals. In mammals the sirtuin family
comprises seven pro-teins (SIRT1–SIRT7),
which vary in tissue specificity, subcellular
localization, enzymatic activity and targets. The
sirtuin has emerged as important regulators of
diverse physiological and pathological events,
including life-span extension, neurodegenerat-
ion, age-related disorders, obesity, heart
disease, inflammation, and cancer.1-4
Sirtuin, notably SIRT1, have been studied
for their role in cancers in past decade.
However, controversy regarding relationship
between sirtuin and cancers exists and is still
under debate since it could act as either a tumor
supressor or tumor promotor.2,5 On one hand,
SIRT1 helps protect DNA from damage and
oxidatif stress, maintains genomic stability, and
limits activity in tumor cell growth.All of which
suggest that SIRT1 would protect organism
against cancer. On the other hand, SIRT1
promots cell survival under stress conditions
that could directly involved in tumorigenesis.
In addition, SIRT1 suppresses the function of
several tumor suppressors including p53, p73
and HIC1 that promots in tumor development
and progression.2,5-7
Proliferating Cell NuclearAntigen (PCNA)
is proven to be a potential prognostic marker in
breast cancer. Increased PCNA expression is
associated with the increased of traditional
prognostic factors value histological grading
and tumor size.8,9 In order to evaluate the role
of SIRT1 in breast cancer and to find an
alternative potential prognostic marker, this
study was conducted to evaluate the association
between SIRT1 expression and histological
grading, tumor size, and PCNA expression in




This was quasi experimental study with post
test only control group design. Thirty Sprague
Dawley female rats (23 days old) were obtained
from LPPT (Laboratorium Pengujian dan
Penelitian Terpadu/Integrated Research and
Testing Laboratory), Uiversitas Gadjah Mada,
Yogyakarta. Rats were haused five in each cage
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in room temperature on a 12-hour cycles of dark
and light. Rats were fed a standard food
laboratory and provided an access to water ad
libitum.
Breast carcinoma induction
After an acclimatization period of one week
at 30 days of age, rats were randomly allocated
to three groups with 10 rats in each group. Group
1 as negative control was just fed the standard
food. Group 2 as vehicle control was fed the
standard food and corn oil. Group 3 as induction
group was fed the standard food and induced
with DMBA at dose of 20 mg/kg body weight
(BW) in corn oil twice a week for five weeks
as conducted by Meiyanto et al.10 All rats were
kept under previously described environmental
conditions and palpated weekly using slide
caliper to determine the appearance, size and
location of tumors. Sixteen weeks after DMBA
induction rats were sacrified. The rats were
anesthetized using diethyl ether. Dissection was
performed on thoracic and abdominal mammary
glands and mammary tumors were removed.
Histological preparations were then processed
for SIRT1 and PCNA expression examination
as well as histological grading. This study has
approved by Medical and Health Research
Ethics Committee, Faculty of Medicine,
Universitas Gadjah Mada, Yogyakarta.
Immunohistochemistry Staining
Immunohistochemistry (IHC) for SIRT1 and
PCNA was performed using Trekki Universal
Link Detection System, in 4-m sections of
formalin-fixed, paraffin-embedded breast
tissues, as well as breast carcinoma tissues.
Endogenous peroxidase was quenched by
incubation of 0.3% hydrogen peroxide for 15
minutes at room temperature. The sections were
immersed in citrate buffer solution for 25
minutes at high temperature to retrieve the
antigen, followed by incubation of primary
antibody, SIRT1 monoclonal antibody 1:400
(Abcam110304) for overnight, and PCNA
polyclonal antibody 1:1000 (Bioscience
8120365) for 10 minutes.Acell was considered
as SIRT1 positive if a brown color of the cell
was identified, whereas tissue was considered
as SIRT1-positive if more than 30% of the cells
showed SIRT1 positive.11
Histological Grading
Histological grading was performed in
Hematoxylin Eosin stained sections.According
to the Elston-Ellis modified Bloom Richardson
classification system, the grade for each section
was derived from an assessment of tubule
formation, nuclear pleomorphism, and mitotic
counts, with each feature being scored 1 to 3
points.12 The scores were added to obtain the
histological grade as follows: 3-5 = Grade 1
(Good); 6-7 = Grade 2 (Moderate); and 8-9 =
Grade 3 (Poor). Mitotic feature was visualized
using the immunohistochemistry method for
PCNA.
Statistical Analysis
SIRT1 expressions between the 3
experimental groups were compared using
statistical analysis of one-way ANOVA. The
differences in SIRT1 expression based on the
histological appearance (normal or carcinoma)
were analyzed by Independent t-test. The
association between SIRT1 expression (cut-off
point 30%) and histological grading was
analyzed by Spearman test, while Pearson
correlation test was applied to analyze the
association between SIRT1 expression and
tumor size, as well as PCNA expression.
RESULTS
A total of 10 female rats were induced with
DMBA in Group 3, six (60%) of which appear
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nodules with microscopic features of breast
carcinoma (TABLE 1 and FIGURE 1). The
number of total nodules that emerged during 16
weeks of observations was 7 nodules. Nodules
first appeared at week 4 after the first DMBA
induction (1 rats). Last nodules appeared at
week 10 after the first DMBA induction (1 rats).
The mean latency time of nodules appearance
was 6.4 weeks, whereas the nodule size varied
from 60 to 18,790 mm3. Histological
classification of the breast tissue using
hematoxilin eosin staining showed normal
breast tissue in Group 1 and 2, as well as ductal
type of breast carcinoma in Group 3 (FIGURE
1). The six rats with nodules were then
analyzed, while 4 rats with neither nodule nor
microscopic features of breast carcinoma were
excluded from the study. No nodules were
observed in all rats of Group 1 and 2.
TABLE 1. Characteristics of Sprague Dawley rats breast carcinoma after
induction with DMBA
A B C
FIGURE 1. Histological appearance of the breast tissue of Sprague Dawley rats in the 3
experimental groups (HE, 400x). A. Normal gland of rats in Group 1; and B. Group 2.
Single cuboids’ cells lining the ducts (black arrow); C. Ductal carcinoma with the
proliferation of pleomorphic cells in Group 3
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TABLE 2 showed the SIRT1 expression of
the three groups, whereas FIGURE 2 showed
the breast carsinoma tissue with SIRT1
expression negative and positive. Significantly
difference in SIRT1 expression between the
three groups was observed in this study (p =
0.000). The SITR1 expression in Group 3
(26.13 ± 1.55%) was significantly higher than
those in Group 1 (0.05 ± 0.01%) and 2 (0.06 ±
0.01%) (p = 0.04). It was indicated that the
SIRT1 expression in the breas carcinoma tissue
was higher than those in breast normal tissue.
Furthermore, Pearson analysis showed
significant positive correlation between SIRT1
expression and tumor size (p = 0.009; r = 0.877).
TABLE 2.The SIRT1 expression and histological type on the three groups
FIGURE 2. SIRT1 expression in the Sprague Dawley rats breast carcinoma tissue induced by
DMBA (400x). A. SIRT1 negative tissue; B. SIRT1 positive tissue
FIGURE 3 showed the breast carcinoma
tissue with PCNA negative and positive.
Furthermore, Pearson analysis showed
significant positive correlation between SIRT1
expression PCNA expression (p = 0.000; r =
0.790).
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FIGURE 3. PCNA expression in Sprague Dawley the breast carcinoma induced by DMBA (400x).
A. PCNA expression positive cells (black arrow). B. PCNA expression negative (black
arrow)
Histological grading of the breast
carcinoma tissue is presented in TABLE 4.
SIRT1 expression postive was observed mostly
in poor histological grade carcinoma. In
contrast, it was not observed in good
histological grade carcinoma. However,
Pearson analysis showed no significantly
correlation between SIRT1 expression and
hitological grading in the breast carcinoma
tissue (p = 0.097; r = 0.285).
TABLE 3. The correlation between SIRT1 expression and histological grading in the Sprague
Dawley rats breast carcinoma tissue induced by DMBA
DISCUSSION
This study showed that SIRT1 expression
in the breast carcinoma tissue of Sprague
Dawley rats induced by DMBA was
significantly higher than its expression in those
normal tissue. This finding indicated that SIRT1
acts as tumor promotor that cause breast
carcinoma progression of the rats. The role of
SIRT1 as tumor promotor was supported by the
increase tumor size as well as PCNA expression.
Previous studies on breast carcinoma, as
well as other type of cancer, such as prostate
and colon cancer, proved that SIRT1 expression
was higher in cancer tissue compared to normal
tissue.12-14 The mechanism by which SIRT1
stimulates the progression of breast carcinoma
can be explained by its deacetylation activity
on pro-apoptotic substrate target, such as p53,
E2F1, Foxo, RB, and Ku70.15,21 SIRT1 is
regulated at transcriptional, translational, and
post-translational levels. A few proteins have
been reported to modulate the expression and
function of SIRT1 protein, such as E2F1, c-
MYC, HIC1, and Foxo 3a, at the level of
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transcription22,23 at the level of translation
(HuR),24 and also DBC1 at the level of post-
translation.25,26
The association between SIRT1 expression
and histological grading showed that SIRT1-
positive was observed mostly in poor
histological grade carcinomas and no SIRT1-
positive was found in good histological grade
carcinoma. However, there was no significantly
correlation between SIRT1 expression and
histological grading in the breast carcinoma of
rats induced by DMBA. The small sample size
(35 slides from 6 rats), and case distribution (2
sections of grade 1; 18 sections of grade 2; and
15 sections of grade 3) might be the cause of
this insignificant result.
The increased of SIRT1 expression will
also increased the SIRT1 deacetylation activity
to several pro-apoptotic proteins, such as E2F1,
RB, p53, and Foxo. Those activities result in
the progressivity of breast carcinoma, indicated
by the decreased form of tubular structure
(tubulus formation), which was caused by the
growth of proliferating carcinoma cells, as well
as the higher mitotic activity in histological
grading analysis.
Present study also showed positive
correlation between SIRT1 expression and
tumor size, as well as PCNAexpression. SIRT1
deacetylation activity to several pro-apoptotic
proteins was assumed as the cause of
proliferative signal hyperactivity, marked by the
increased of tumor size, as well as PCNA
expression, along with the increased of SIRT1
expression in this kind of animal experimental
model.
CONCLUSION
In conclusion, there is relationship between
SIRT1 expression and tumor size as well as
PCNA expression in rat breast carcinoma
induced by DMBA. However, this result should
be confirmed by further study concerning SIRT1
deacetylation activity on target proteins as well
as regulator proteins of SIRT1.
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